Effectiveness and safety of vedolizumab in a matched cohort of elderly and young Inflammatory Bowel Disease patients - LIVE Study-Group

被引：0
|
作者：
Pugliese, D. [1 ]
Privitera, G. [2 ]
Armuzzi, A. [3 ]
机构：
[1] Fdn Policlin Univ Agostino Gemelli IRCCS, CEMAD IBD UNIT, Unita Operat Complessa Med Interna & Gastroentero, Rome, Italy
[2] Univ Cattolica Sacro Cuore, Dipartimento Univ Med & Chirurg Traslaz, Rome, Italy
[3] Univ Cattolica, Fdn Policlin Univ Agostino Gemelli IRCCS, CEMAD IBD Unit, Unita Operat Complessa Med Interna & Gastroentero, Rome, Italy
来源：
JOURNAL OF CROHNS & COLITIS | 2021年 / 15卷
关键词：
D O I：
10.1093/ecco-jcc/jjab073.088
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
DOP49
引用
收藏
页码：S085 / S085
页数：1
相关论文
共 50 条
  • [31] Effectiveness, safety, and drug sustainability of biologics in elderly patients with inflammatory bowel disease: A retrospective study
    Gustavo Drügg Hahn
    Jean-Frédéric Le Blanc
    Petra Anna Golovics
    Panu Wetwittayakhlang
    Abdulrahman Qatomah
    Anna Wang
    Levon Boodaghians
    Jeremy Liu Chen Kiow
    Maryam Al Ali
    Gary Wild
    Waqqas Afif
    Alain Bitton
    Peter Laszlo Lakatos
    Talat Bessissow
    World Journal of Gastroenterology, 2022, 28 (33) : 4823 - 4833
  • [32] Three-year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multi-centre cohort study
    Amiot, Aurelien
    Serrero, Melanie
    Peyrin-Biroulet, Laurent
    Filippi, Jerome
    Pariente, Benjamin
    Roblin, Xavier
    Buisson, Anthony
    Stefanescu, Carmen
    Trang-Poisson, Caroline
    Altwegg, Romain
    Marteau, Philippe
    Vaysse, Thibaud
    Bourrier, Anne
    Nancey, Stephane
    Laharie, David
    Allez, Matthieu
    Savoye, Guillaume
    Moreau, Jacques
    Vuitton, Lucine
    Viennot, Stephanie
    Bouguen, Guillaume
    Abitbol, Vered
    Fumery, Mathurin
    Gagniere, Charlotte
    Bouhnik, Yoram
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2019, 50 (01) : 40 - 53
  • [33] VEDOLIZUMAB IS EFFECTIVE AND SAFE TO USE IN ELDERLY PATIENTS WITH INFLAMMATORY BOWEL DISEASE COMPARED TO GENERAL POPULATION - A MATCHED CASE CONTROL STUDY
    Shashi, Preeti
    Gopalakrishnan, Dharmesh
    Parikh, Malav P.
    Shen, Bo
    Kochhar, Gursimran
    GASTROENTEROLOGY, 2018, 154 (06) : S836 - S837
  • [34] Efficacy and Safety of Vedolizumab in Patients with Inflammatory Bowel Disease in Association with Vedolizumab Drug Levels
    Huettemann, Eva
    Muzalyova, Anna
    Groehl, Katharina
    Nagl, Sandra
    Fleischmann, Carola
    Ebigbo, Alanna
    Classen, Johanna
    Wanzl, Julia
    Prinz, Friederike
    Mayr, Patrick
    Schnoy, Elisabeth
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (01)
  • [35] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT
    Pugliese, Daniela
    Privitera, Giuseppe
    Crispino, Federica
    Mezzina, Nicolo
    Pellegrini, Lucienne
    Laterza, Lucrezia
    Viola, Anna
    Soru, Pietro
    Scrivo, Barbara
    Barberio, Brigida
    Ricci, Chiara
    Pluchino, Dario
    Scribano, Maria Lia
    Bertani, Lorenzo
    Sablich, Renato
    Pastorelli, Luca
    Manguso, Francesco
    Variola, Angela
    Di Sario, Antonio
    Grossi, Laurino
    Ribaldone, Davide Giuseppe
    Biscaglia, Giuseppe
    Buda, Andrea
    Balestrieri, Paola
    Mocci, Giammarco
    Viscido, Angelo
    Di Paolo, Maria Carla
    Onali, Sara
    Rodino, Stefano
    Coletta, Marina
    Principi, Mariabeatrice
    Miranda, Agnese
    Amato, Arnaldo
    Bezzio, Cristina
    Petruzzellis, Carlo
    Mazzuoli, Silvia
    Festa, Stefano
    Sartini, Alessandro
    Fanigliulo, Libera
    Gallina, Sara
    Bodini, Giorgia
    Guidi, Luisa
    Savarino, Edoardo
    Cappello, Maria
    Caprioli, Flavio
    Fries, Walter
    Scaldaferri, Franco
    Castiglione, Fabiana
    Massari, Alessandro
    Orlando, Ambrogio
    GASTROENTEROLOGY, 2020, 158 (06) : S441 - S441
  • [36] The Effect of Vedolizumab on Spondyloarthritis Symptoms in a Cohort of Inflammatory Bowel Disease Patients
    Huseynzada, Sinakhanim
    Inel, Tuba Yuce
    Hajiyev, Farid
    Avsar, Aydan Koken
    Balci, Ali
    Akpinar, Hale
    Onen, Fatos
    Sari, Ismail
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (02) : 50 - +
  • [37] Italian real-life study evaluating the long-term effectiveness of vedolizumab for the treatment of inflammatory bowel disease: the elderly cohort
    Pugliese, D.
    Privitera, G.
    Armuzzi, A.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S419 - S420
  • [38] Safety and Efficacy of Vedolizumab in Elderly Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis
    Dahiya, Dushyant S.
    Chandan, Saurabh
    Bapaye, Jay
    Mohan, Babu P.
    Ramai, Daryl
    Kassab, Lena L.
    Chandan, Ojasvini C.
    Dulai, Parambir S.
    Kochhar, Gursimran S.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S627 - S627
  • [39] ITALIAN REAL-LIFE STUDY EVALUATING THE LONG-TERM EFFECTIVENESS OF VEDOLIZUMAB FOR THE TREATMENT OF INFLAMMATORY BOWEL DISEASE: THE ELDERLY COHORT
    Pugliese, Daniela
    Privitera, Giuseppe
    Armuzzi, Alessandro
    GASTROENTEROLOGY, 2021, 160 (06) : S43 - S43
  • [40] DYSPLASIAS IN INFLAMMATORY BOWEL-DISEASE AND THE STUDY-GROUP FOR THE CLASSIFICATION OF INFLAMMATORY BOWEL-DISEASE MORPHOLOGY
    OTTO, HF
    PATHOLOGE, 1989, 10 (04): : 240 - 243
12345